In vitro keratinase activity analysis
The variation of keratinase activity at different pH levels and different temperatures during the experimental period is presented in Table 2. The results indicate that enzyme activity is significantly inhibited at pH 2.5, suggesting a temporary suppression of enzyme activity in the gastric environment. Keratinase activity substantially increases at pH 6.8, simulating the intestinal environment. The enzyme activity is most significant at 39
oC, while it significantly decreases at the high temperature of 90
oC.
Short-term in vivo safety analysisÿ
Throughout the entire administration period, no adverse reactions or severe adverse reactions related to the consumption of keratinase and psyllium husk powder were observed based on weekly vital signs and physical examinations. The results of blood routine examinations and various laboratory indicators related to liver and kidney functions are presented in Table 3 to 4.
Blood routine examination results
Blood routine examinations were conducted on days 0 and 14 of the experiment. The indicators and normal reference ranges are shown in Table 3-4. The changes in the experimental groups and the blank control group at Days 0, 14.
Throughout the experiment, no significant differences (P>0.05) were observed across all measured parameters, including inflammatory cell counts, red blood cell-related indices, platelet-related markers and indicators of liver and renal injury. The counts of WBC, NEUT and LYM remained stable within normal ranges, showing no notable variation between experimental and control groups. Similarly, red blood cell parameters such as RBC, HGB, HCT, MCV and MCH exhibited minor fluctuations over time but remained within physiological limits, with no significant differences among experimental groups or in comparison to the control. Platelet-related parameters, including PLT, MPV, PCT and PDW, followed the same trend, showing only slight variations while maintaining stability. Additionally, markers related to liver and renal function fluctuated within normal limits without statistically significant changes. Overall, all measured indicators demonstrated consistency throughout the study, indicating that the experimental conditions did not induce any adverse physiological effects.
Efficacy analysis
Incidence of trichobezoars in the faeces
As shown in (Fig 2A), we collected trichobezoars of various sizes in the feces. In day 14, cats in the KP-H group produced more feces compared with Control group, with a significant increase in trichobezoars in the feces (Fig 2B-C). At the same time, the number of small hairballs in the feces of the KP-H group increased, while the number of large hairballs decreased (Table 5).
Changes in short-chain fatty acid indicators
The changes in short-chain fatty acid indicators are shown in (Fig 2). As shown in (Fig 3A), total intestinal SCFA increased in a dose-dependent manner with KP supplementation. Compared with the Control group, the KP-H group significantly increased the contents of acetic acid, propionic acid, butyric acid and isobutyric acid and the effect of KP-L was weaker than that of the KP-H group (Fig 3B-E). In addition, KP supplementation did not affect the contents of valeric acid, isovaleric acid and hexanoic acid (Fig 3F-G).
Coomassie brilliant blue method
The keratin content in feces during the experiment is shown in (Fig 4). Samples from KP-H group showed a higher keratin content compared to the control group.
During the in vitro experiment, the biological activity of certain keratinas used was tested under pH 2.5 and pH 6.8, the enzyme activity showed more rapid movement under pH 6.8 compared to pH 2.5. While higher enzyme activity was spotted at the temperature of 39
oC.
A short-term
in vivo safety assessment of various dosages of keratinase-psyllium husk showed no significant negative impact on the hepatorenal function of the tested subjects. The combination of keratinase and psyllium husk as a feed additive is rare, so the effect of this combination on overall health was carefully observed during the initial phase of our experiment. Our results indicated that supplementation with keratinase-psyllium husk did not significantly affect the blood routine or serological indices of the animals. While keratinase is widely used as a feed additive, its thermal stability remains a subject of ongoing discussion (
Singh and Kushwaha, 2015). The inclusion of psyllium husk in human diets has been shown to be beneficial in lowering serum cholesterol and other studies have demonstrated that psyllium-enriched extruded dry diets can positively impact feline constipation
(Wolever et al., 1994; Freiche et al., 2011).Similar to the observed variability in growth performance among lambs fed sprouted barley
(Alharthi et al., 2024), the impact of keratinase-psyllium husk supplementation may depend on factors such as dosage, dietary composition and individual differences.
Considering individual differences in the experiment, in trial KP-H group, there was a significant increase in keratin content compared to the control group in the Coomassie Brilliant Blue test, indicating a certain effect of keratinase on hair degradation and hairball prevention. These results suggest that the administration of keratinase in combination with psyllium husk powder leads to an increased degradation of keratin in the feline gastrointestinal tract, resulting in higher keratin content in feces. The increase in keratin content in the feces on D14 indicates effective breakdown and subsequent excretion of keratin, particularly in KP-H Group, where the increase was most pronounced. This demonstrates the efficacy of keratinase in degrading keratin under the experimental conditions.
In the KP-H trial group, there was a significant increase (P<0.05) in the levels of acetic acid, isovaleric acid and isobutyric acid in feces, indicating that the formula had a positive effect on degrading keratin in the gastrointestinal tract, as expected. Carbohydrates, meanwhile, pass through the upper digestive system and are fermented by gut bacteria in the cecum and large intestine (
Roy et al., 2006). Furthermore, keratin degradation by keratinase begins with disulfide bond reduction by disulfide reductase, followed by keratinolytic protease K1 unwinding and cleaving the keratin fibers. Finally, keratinolytic protease K2 breaks down the resulting peptides into amino acids
(Nnolim et al., 2020). Additionally, recent studies have shown that Astragalus polysaccharides enhance the intestinal barrier by increasing the levels of isobutyrate in the gut. Isobutyrate is a short-chain fatty acid that promotes the health of intestinal epithelial cells, maintaining the integrity of the intestinal barrier and reducing the risk of harmful substances entering the bloodstream through the gut wall (
Yang et al., 2024). Under normal conditions, fiber fermentation produces short-chain fatty acids (SCFAs) such as acetate, propionate and butyrate, which are crucial for gut health. However, SCFA production decreases when microbes switch to amino acids or fats due to a shortage of fermentable fibers (
Koh et al., 2016). This fermentation process produces various metabolites, with SCFAs being the most prominent. Importantly, SCFAs such as acetate, propionate and butyrate account for about 95% of these metabolites and play a vital role in maintaining microbial balance in the gut’s anaerobic environment. Around 95% of SCFAs are absorbed in the intestines, while the remaining 5% are excreted in feces (
Cook and Sellin,1998). Moreover, the relative proportions of each SCFA depend on several factors, including the substrate, the composition of gut microbiota and the transit time through the digestive system. Approximately 500-600 mM of SCFAs are produced daily in the large intestine, with the amount being largely influenced by dietary fiber intake. However, psyllium and gums do not contribute to this process (
Canfora et al., 2015;
Macfarlane and Macfarlane, 2003).
The increase in stool quantity associated with higher dietary fiber intake in the large intestine may result from changes in microbial populations or alterations in the transit time through the large bowel (
Hall et al., 2013). In fact, studies have shown that dietary fiber can influence transit time (
Lewis et al., 1994). Gut transit time affects the balance between saccharolytic and proteolytic fermentation, while gut microbiota can stimulate gut motility, thereby impacting transit time and SCFA production. This study highlights the direct relationship between gut transit time and the formation of SCFAs (
Procházková et al., 2023). Furthermore, increasing evidence suggests that SCFAs offer various health benefits, such as enhancing the gut barrier (
Chen et al., 2018), regulating brain functions by promoting intestinal gluconeogenesis and helping to control appetite, glucose and lipid metabolism (
De Vadder et al., 2014;
Frost, 2014).